Merck overview
Stories about Merck
Biotech bet pays big in Merck exit
Lebanon, New Hampshire-based GlycoFi will be acquired by Merck in an exit coup for the biotech company’s venture backers.
CD&R completes $1.65bn VWR deal
Clayton, Dubilier & Rice takes over the laboratory supplies company from pharmaceuticals group Merck, putting $450m of its own equity toward the deal.
CD&R commits $600m to distribution carve-out
Clayton, Dubilier & Rice has agreed to acquire VWR International, a distributor of laboratory supplies, from pharmaceuticals group Merck in a $1.65bn leveraged carve-out.
Merck contact information
Offices
Contacts
| Name | Job title | Location | |
|---|---|---|---|
Job titleExecutive Vice President and Chief Financial Officer | LocationRahway, United States | Email | |
Merck fund commitments
Known fund commitments: 1
| Fund | Manager | Commitment date | Commitment size |
|---|---|---|---|
Manager | Commitment date- | Commitment size- | |
Stories that mention Merck
Future 40: Who’s showing private equity leadership?
Who are the young guns showing innovation in the industry? Who has the X factor that marks them as a future leader? Our Future 40 list of the 40 individuals aged under 40 set to shape private equity over the next decade.
Deal Mechanic: CBPE & Rosemont Pharmaceuticals
In its six years as owner of Rosemont Pharmaceuticals, CBPE helped the business to overhaul its manufacturing process, expand its product line and bolster its management team – more than doubling EBITDA in the process.
Frazier’s More joins Gates Foundation
Healthcare investing veteran Bob More has joined the Gates Foundation to help develop a ‘venture capital initiative’ in support of global health.
Jordan Company exits medical supplier for $850m
GS Capital Partners and Clayton Dubilier & Rice are teaming up to buy Harrington Holdings from The Jordan Company, which first invested in the company in 2007.
US charges 14, alleging insider trading on PE deals
An 'insider trading network' allegedly paid cash in exchange for tips on deals backed by Silver Lake, TPG, Hellman & Friedman and Blackstone.
CD&R exits from VWR(2)
US buyout firm Clayton, Dubilier & Rice sold VWR International yesterday. The firm also revealed yesterday it was entering into its first ever deal partnership with rival buyout firm KKR.
CD&R exits from VWR
US buyout firm Clayton, Dubilier & Rice sold VWR International yesterday. The firm also revealed yesterday it was entering into its first ever deal partnership with rival buyout firm KKR.
The impact of biotechnology on modern healthcare and drug development
Peter Reinish, partner at Global Life Science Ventures, argues that biotechnology will play a decisive role in the development of the healthcare sector.